Total Payments
$8,155
2024 Payments
$1,936
Companies
33
Transactions
534
Medicare Patients
725
Medicare Billing
$77,243
Payment Breakdown by Category
Food & Beverage$8,135 (99.8%)
Education$19.62 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,135 | 533 | 99.8% |
| Education | $19.62 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,500 | 97 | $0 (2024) |
| PFIZER INC. | $609.07 | 43 | $0 (2024) |
| GlaxoSmithKline, LLC. | $559.24 | 36 | $0 (2024) |
| Lilly USA, LLC | $506.02 | 38 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $431.90 | 25 | $0 (2024) |
| Amgen Inc. | $428.80 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $404.87 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $403.08 | 28 | $0 (2024) |
| Novo Nordisk Inc | $400.77 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $378.47 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,936 | 116 | ABBVIE INC. ($374.93) |
| 2023 | $2,226 | 138 | ABBVIE INC. ($449.27) |
| 2022 | $1,749 | 126 | ABBVIE INC. ($320.55) |
| 2021 | $2,245 | 154 | AbbVie Inc. ($354.84) |
All Payment Transactions
534 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 190 | 522 | $63,195 | $23,084 |
| 2022 | 7 | 209 | 719 | $72,598 | $26,106 |
| 2021 | 7 | 228 | 635 | $58,890 | $23,537 |
| 2020 | 2 | 98 | 146 | $18,382 | $4,517 |
Total Patients
725
Total Services
2,022
Medicare Billing
$77,243
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 313 | $37,540 | $14,835 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 67 | $11,055 | $4,172 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $9,000 | $3,045 | 33.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 79 | $3,950 | $562.78 | 14.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,650 | $468.27 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 457 | $54,808 | $21,893 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 40 | $6,600 | $1,777 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $3,600 | $1,240 | 34.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 107 | $5,350 | $857.70 | 16.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $600.00 | $170.57 | 28.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 16 | 80 | $1,200 | $93.65 | 7.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $440.00 | $73.91 | 16.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 377 | $44,755 | $20,171 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $5,700 | $2,014 | 35.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 29 | 102 | $5,100 | $753.39 | 14.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 28 | 28 | $1,400 | $408.80 | 29.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $480.00 | $93.80 | 19.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 20 | 79 | $1,095 | $89.90 | 8.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 11 | 18 | $360.00 | $5.72 | 1.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 124 | $15,412 | $3,458 | 22.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 22 | $2,970 | $1,059 | 35.6% |
About Ginger Webb, APRN
Ginger Webb, APRN is a Nurse Practitioner healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1770990061.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ginger Webb, APRN has received a total of $8,155 in payments from pharmaceutical and medical device companies, with $1,936 received in 2024. These payments were reported across 534 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,135).
As a Medicare-enrolled provider, Webb has provided services to 725 Medicare beneficiaries, totaling 2,022 services with total Medicare billing of $77,243. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Adult Health
- Location Pikeville, KY
- Active Since 07/17/2014
- Last Updated 09/01/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1770990061
Products in Payments
- UBRELVY (Drug) $638.63
- NURTEC ODT (Drug) $507.28
- JARDIANCE (Drug) $435.39
- TRINTELLIX (Drug) $431.90
- TRELEGY ELLIPTA (Drug) $420.17
- VRAYLAR (Drug) $415.13
- QULIPTA (Drug) $273.83
- ENTRESTO (Drug) $269.48
- Kerendia (Drug) $260.18
- ELIQUIS (Drug) $223.52
- MOUNJARO (Drug) $220.64
- BELSOMRA (Drug) $214.87
- RELISTOR (Drug) $191.45
- Rybelsus (Drug) $185.35
- TRULICITY (Drug) $181.52
- Aimovig (Biological) $166.27
- Prolastin-C Liquid (Biological) $164.31
- FARXIGA (Drug) $161.44
- XARELTO (Drug) $161.25
- Otezla (Drug) $159.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Pikeville
Staci Taylor, Aprn, APRN
Nurse Practitioner — Payments: $9,527
Nurse Practitioner $9,527
Elizabeth Branham, Aprn, APRN
Nurse Practitioner — Payments: $7,078
Nurse Practitioner $7,078
Kendra Drake, Aprn, APRN
Nurse Practitioner — Payments: $6,951
Nurse Practitioner $6,951
Dr. Mark Reed, M.d, M.D
Nurse Practitioner — Payments: $4,197
Nurse Practitioner $4,197
Angela Webb
Nurse Practitioner — Payments: $4,058
Nurse Practitioner $4,058
Betty Reynolds, Aprn, APRN
Nurse Practitioner — Payments: $3,559
Nurse Practitioner $3,559